TScan Therapeutics

Erasca’s IPO leads the way as three cancer biotechs raise $534M for clinical trials
MedCity News
Sun, 07/18/21 - 09:49 pm
Erasca
IPOs
clinical trials
Imago BioSciences
TScan Therapeutics